Cian Duggan
CEO

Resurrect Bio utilizes proprietary FloraFold® AI and a rapid plant platform to discover novel crop defense traits. This technology resurrects R-genes, enabling crops to naturally defend against pathogens and pests. The company offers a high-throughput workflow that accelerates trait discovery significantly faster than conventional methods.
Raised to date
$2MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.



Modern agricultural practices, including monoculture and selective breeding for yield, have reduced genetic diversity in crops, making them vulnerable to evolving plant diseases. Climate change is exacerbating this issue by spreading diseases to new geographic locations, overwhelming existing crop resistance. Chemical controls are environmentally damaging and pathogens evolve to overcome them, necessitating new approaches to crop protection.
Resurrect Bio employs gene editing to restore lost or weakened immune resistance genes (R-genes) in crops, enhancing their natural ability to defend against diseases. The company reconstitutes networks of immune receptors in model species, using accelerated techniques to achieve results in days rather than years. By leveraging insights into plant immune receptor networks and pathogen effector biology, Resurrect Bio aims to fortify crop immune systems. This approach offers a more precise and sustainable alternative to chemical controls, reducing environmental impact and promoting genetic diversity.
Resurrect Bio's primary customers are farmers and agricultural companies seeking sustainable and effective solutions to protect crops from evolving diseases, particularly in the face of climate change.